MOLLAVELİOĞLU, B. Et Al. 2022. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer. WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.20, no.1 .

MOLLAVELİOĞLU, B., ÇETİN, E., CABIOĞLU, N., Abbasov, A., ÖNDER, S., EMİROĞLU, S., ... TÜKENMEZ, M.(2022). High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer. WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.20, no.1.

MOLLAVELİOĞLU, Baran Et Al. "High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer," WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.20, no.1, 2022

MOLLAVELİOĞLU, Baran Et Al. "High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer." WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.20, no.1, 2022

MOLLAVELİOĞLU, B. Et Al. (2022) . "High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer." WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.20, no.1.

@article{article, author={Baran MOLLAVELİOĞLU Et Al. }, title={High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer}, journal={WORLD JOURNAL OF SURGICAL ONCOLOGY}, year=2022}